CS logo
small CS logo
Katayama Medical Clinic

Kurashiki, Okayama, Japan
Internist in Kurashiki
〒710-0813 Okayama, Kurashiki, Kotobukicho, 1−26 マツダパーキングビル 1F

About Katayama Medical Clinic


"倉敷市で内科・神経内科をお探しなら【片山内科クリニック】 当院の診療科目は内科、神経内科、もの忘れ外来、認知症外来となっております。 内科では、血液検査、尿検査、心電図検査を行っております。 神経内科では、頸動脈エコー、嗅覚検査・膀胱内残尿量測定、夜間無呼吸検査などを行っております。 物忘れ・認知症外来では、認知機能・心理テスト 簡易~複雑検査、認知機能の評価と低下しているときの原因診断を行っています。 診断して、どのように生活するのか、進行予防の説明、福祉、地域連携の説明をさせて頂いております。 何かお困りごとがございましたら当院へお気軽にご相談ください。"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AstraZeneca
2
Eli Lilly and Company
2
Pfizer
2
Listen Trial Group
1
Positive Trial Group
1
Total Rows: 5

Clinical Trials at Katayama Medical Clinic


During the past decade, Katayama Medical Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100110000111111001111220000Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments
2010-07-01
Terminated
10,000
LIpid Lowering With Highly Potent Statins in Hyperlipidaemia With Type 2 Diabetes patiENts
2012-03-01
Completed
1,049
An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease
2014-09-30
2018-10-04
Terminated
2,218
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
2014-11-18
2017-03-15
Completed
209
A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).
2015-06-25
2017-12-06
Completed
597
A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia
2017-03-15
2018-10-02
Terminated
421
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
2020-06-19
2025-08-22
Active, not recruiting
1,800
A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease
2021-09-16
2024-06-13
Active, not recruiting
330

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Katayama Medical Clinic" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Listen Trial Group" with 1 trials sponsored and "Positive Trial Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Katayama Medical Clinic" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAstraZeneca: 2AstraZeneca: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Pfizer: 2Pfizer: 2Listen Trial Group: 1Listen Trial Group: 1Positive Trial Group: 1Positive Trial Group: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2

Clinical Trials Conditions at Katayama Medical Clinic


According to Clinical.Site data, the most researched conditions in "Katayama Medical Clinic" are "Alzheimer Disease" (2 trials), "Rheumatoid Arthritis" (2 trials), "Alzheimer's Disease" (1 trials), "Alzheimer´s Disease" (1 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "Katayama Medical Clinic" in a lesser frequency.

Clinical Trials Intervention Types at Katayama Medical Clinic


Most popular intervention types in "Katayama Medical Clinic" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Lanabecestat" (2 trials), "Rosuvastatin" (2 trials), "Adalimumab" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Katayama Medical Clinic


The vast majority of trials in "Katayama Medical Clinic" are 8 trials for "All" genders.

Clinical Trials Status at Katayama Medical Clinic


Currently, there are NaN active trials in "Katayama Medical Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Katayama Medical Clinic, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Katayama Medical Clinic, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Terminated: 3Terminated: 3Active, not recruiting: 2Active, not recruiting: 2